Infinity Pharmaceuticals Story

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.4  0.12  5.26%

Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance
Infinity Pharmaceuticals and Bristol-Myers Squibb Expand Clinical ...
PR Newswire - Sep 25, 2017 CAMBRIDGE, Mass., Sept. 25, 2017 PRNewswire -- Infinity Pharmaceuticals, Inc. today announced that it has expanded its existing clinical collaboration with Bristol-Myers Squibb evaluating IPI-549 in combination with Opdivo to include ...

Read More...   

Story Momentum

This media report from www.prnewswire.com distributed on September 25, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 3.31% . The trading delta at closing time when the story was published against the current closing price is 100.83% .

Similar stores for Infinity Pharmaceuticals

Buy or Sell Average Brokerage Ratings on Chevron Corporation , Infinity ...wsj  News
Infinity Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -, higher than what Reuters data shows regarding industry average. Infinity Pharmaceuticals, Inc. More In-Depth Monitoring is Needed - StockNewsGazette What the Insider Data Suggests About Infinity Pharmaceuticals, Inc. - NY Stock News
over a week ago at http://www.equities.com 
Infinity Pharmaceuticals Inc. Soars 14.38 percent on October 11
Equities News
Infinity Pharmaceuticals Inc. had a good day on the market for Wednesday October 11 as shares jumped 14.38 percent to close at 1.67. Risky Play or Bargain Update on Infinity Pharmaceuticals, Inc. - Morgan Research Currently Overpriced Or Underpriced Infinity Pharmaceuticals, Inc. INFI ... - Post Analyst
over two weeks ago at http://www.stocknewsjournal.com 
Revenue Approximations Analysis SunTrust Banks, Inc. , Infinity ...
wsj  News
StockNewsJournal - Oct 2, 2017 Infinity Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -, higher than what Reuters data shows regarding industry average. Infinity Pharmaceuticals Inc. Soars 16.67 percent on September 29 - Equities.com A Fresh Look At Infinity Pharmaceuticals, Inc. - TopChronicle
over three weeks ago at http://www.bizjournals.com 
Harvard IT unit taking Cambridge office after Infinity Pharma exits lease
bizjournals News
Boston Business Journal - Sep 26, 2017 When Cambridge-based Infinity Pharmaceuticals exited its lease at 784 Memorial Drive some eight years ahead of schedule, landlord Bulfinch Cos.

Did you try this?

Run Headlines Timeline Now
   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Hide  View All  Next  Launch Headlines Timeline

Shares Outstanding

Shares Outstanding Comparative Analysis
  Shares Outstanding 
      Infinity Pharmaceuticals Comparables 
Infinity Pharmaceuticals is currently under evaluation in shares outstanding category among related companies. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.